JP2015502946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502946A5 JP2015502946A5 JP2014544914A JP2014544914A JP2015502946A5 JP 2015502946 A5 JP2015502946 A5 JP 2015502946A5 JP 2014544914 A JP2014544914 A JP 2014544914A JP 2014544914 A JP2014544914 A JP 2014544914A JP 2015502946 A5 JP2015502946 A5 JP 2015502946A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- targeted delivery
- delivery composition
- glycol
- mmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- AXSJOJBJGZMRRS-UHFFFAOYSA-N CCNN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc1cnccc1)(=O)=O Chemical compound CCNN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc1cnccc1)(=O)=O AXSJOJBJGZMRRS-UHFFFAOYSA-N 0.000 description 1
- AODBRAKDBZHPNM-UHFFFAOYSA-N CN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc(cc1)ccc1O)(=O)=O Chemical compound CN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc(cc1)ccc1O)(=O)=O AODBRAKDBZHPNM-UHFFFAOYSA-N 0.000 description 1
- QURZZKPWFKUXBF-UHFFFAOYSA-N CN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc(cc1)ccc1OC(F)(F)F)(=O)=O Chemical compound CN(CC1)CCC1(C(NO)=O)S(c(cc1)ccc1Oc(cc1)ccc1OC(F)(F)F)(=O)=O QURZZKPWFKUXBF-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161565461P | 2011-11-30 | 2011-11-30 | |
| US61/565,461 | 2011-11-30 | ||
| PCT/US2012/067236 WO2013082389A1 (en) | 2011-11-30 | 2012-11-30 | Mmp-targeted therapeutic and/or diagnostic nanocarriers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502946A JP2015502946A (ja) | 2015-01-29 |
| JP2015502946A5 true JP2015502946A5 (OSRAM) | 2015-08-13 |
Family
ID=47430071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544914A Pending JP2015502946A (ja) | 2011-11-30 | 2012-11-30 | Ｍｍｐ標的化治療用および／または診断用ナノキャリア |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8871189B2 (OSRAM) |
| EP (1) | EP2785635A1 (OSRAM) |
| JP (1) | JP2015502946A (OSRAM) |
| KR (2) | KR20150107894A (OSRAM) |
| CN (1) | CN104080729A (OSRAM) |
| BR (1) | BR112014012746A8 (OSRAM) |
| CA (1) | CA2854194A1 (OSRAM) |
| IL (1) | IL232824A0 (OSRAM) |
| MX (1) | MX2014005749A (OSRAM) |
| RU (1) | RU2014123622A (OSRAM) |
| WO (1) | WO2013082389A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271465A1 (en) * | 2013-03-15 | 2014-09-18 | Mallinckrodt Llc | Matrix metalloprotease (mmp) targeted agents for imaging and therapy |
| US20150231254A1 (en) * | 2014-02-17 | 2015-08-20 | The Royal Institution For The Advancement Of Learning/Mcgill University | Polynucleotide-poly(diol) conjugates, process of preparation and uses thereof |
| US20160058705A1 (en) * | 2014-08-28 | 2016-03-03 | Jayakumar Rajadas | Compositions and methods for treating cardiovascular and pulmonary diseases and disorders with apelin |
| KR101683463B1 (ko) * | 2014-12-19 | 2016-12-08 | 서울대학교산학협력단 | 마이크로버블-리포좀-멜라닌 나노입자 복합체 및 이를 포함하는 조영제 |
| RU2646752C2 (ru) * | 2016-02-25 | 2018-03-07 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Ингибиторы цинк-зависимых металлопротеиназ (ММП-2 и ММП-9) в ряду бензоиламино(фенилсульфонил)-замещенных циклических аминокислот как потенциальные лекарственные средства, препятствующие постинфарктному ремоделированию левого желудочка сердца |
| US11400049B2 (en) | 2016-10-19 | 2022-08-02 | Avive, Inc. | Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases |
| CN111004195B (zh) * | 2019-12-03 | 2022-01-28 | 沈阳药科大学 | 卡巴他赛弱碱性衍生物及其制剂 |
| WO2021167703A1 (en) * | 2020-02-19 | 2021-08-26 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225181A (en) * | 1985-06-07 | 1993-07-06 | The Research Foundation Of State University Of New York | Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi |
| US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| FI113840B (fi) | 2001-03-26 | 2004-06-30 | Ctt Cancer Targeting Tech Oy | Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa |
| FI20031528A0 (fi) | 2003-10-17 | 2003-10-17 | Ctt Cancer Targeting Tech Oy | Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi |
| GB0326546D0 (en) * | 2003-11-14 | 2003-12-17 | Amersham Plc | Inhibitor imaging agents |
| US20060210549A1 (en) | 2004-09-10 | 2006-09-21 | Srivastava Devendra K | Controlled release liposomes and methods of use |
| WO2006090813A1 (ja) | 2005-02-25 | 2006-08-31 | National University Corporation Hokkaido University | 腫瘍組織で選択的に分解性を示す血中滞留性素子 |
| US20090246142A1 (en) | 2006-03-10 | 2009-10-01 | Massachusetts Institute Of Technology | Triggered Self-Assembly of Nanoparticles In Vivo |
| US7618992B2 (en) * | 2006-12-29 | 2009-11-17 | Astellas Pharma Inc. | Method of treating cancer by co-administration of anticancer agents |
| WO2010012473A2 (en) | 2008-07-30 | 2010-02-04 | Charite - Universitätsmedizin Berlin | Hydrolase-specific nanosensors, methods for producing them and uses in molecular imaging |
| US8889631B2 (en) | 2008-08-18 | 2014-11-18 | The University Of Kansas | Disruptors of early/recycling endosomes |
| EP2416763A4 (en) | 2009-04-06 | 2015-05-06 | Mayo Foundation | PROCESS AND MATERIALS FOR THE RELEASE OF MOLECULES |
| CA2770980A1 (en) | 2009-07-15 | 2011-01-20 | Roger Y. Tsien | Peptides whose uptake in cells is controllable |
| WO2011139343A2 (en) * | 2010-04-28 | 2011-11-10 | Wu Nian | Amino acid linked peg-lipid conjugates |
-
2012
- 2012-11-29 US US13/689,694 patent/US8871189B2/en not_active Expired - Fee Related
- 2012-11-30 CN CN201280067193.1A patent/CN104080729A/zh active Pending
- 2012-11-30 BR BR112014012746A patent/BR112014012746A8/pt not_active IP Right Cessation
- 2012-11-30 KR KR1020157024031A patent/KR20150107894A/ko not_active Withdrawn
- 2012-11-30 JP JP2014544914A patent/JP2015502946A/ja active Pending
- 2012-11-30 MX MX2014005749A patent/MX2014005749A/es unknown
- 2012-11-30 KR KR1020147014186A patent/KR20140096080A/ko not_active Withdrawn
- 2012-11-30 CA CA2854194A patent/CA2854194A1/en not_active Abandoned
- 2012-11-30 WO PCT/US2012/067236 patent/WO2013082389A1/en not_active Ceased
- 2012-11-30 RU RU2014123622A patent/RU2014123622A/ru not_active Application Discontinuation
- 2012-11-30 EP EP12806235.3A patent/EP2785635A1/en not_active Withdrawn
-
2014
- 2014-05-27 IL IL232824A patent/IL232824A0/en unknown
- 2014-09-18 US US14/490,357 patent/US20150004097A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502946A5 (OSRAM) | ||
| Wang et al. | Diagnostic imaging and therapeutic application of nanoparticles targeting the liver | |
| Clementi et al. | Dendritic poly (ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms | |
| Zhong et al. | Conjugation to poly (amidoamine) dendrimers and pulmonary delivery reduce cardiac accumulation and enhance antitumor activity of doxorubicin in lung metastasis | |
| Pan et al. | PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy | |
| Miller et al. | Premature drug release of polymeric micelles and its effects on tumor targeting | |
| Gao et al. | PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking | |
| JP2013538829A5 (OSRAM) | ||
| Shirbin et al. | Cisplatin-induced formation of biocompatible and biodegradable polypeptide-based vesicles for targeted anticancer drug delivery | |
| KR101815030B1 (ko) | 킬레이트 복합 미셀을 가지는 약물 전달체 및 그 응용 | |
| Bonzi et al. | Novel pullulan bioconjugate for selective breast cancer bone metastases treatment | |
| Lim et al. | The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers | |
| US20140303329A1 (en) | Method of manufacturing a pharmaceutical composition having chelating type complex micelles | |
| CA3137081A1 (en) | Compositions and methods of manufacturing star polymers for ligand display and/or drug delivery | |
| US20210393523A1 (en) | Aromatic ring substituted amphiphilic polymers as drug delivery systems | |
| EP2750712A2 (en) | Nanoparticle peg modification with h-phosphonates | |
| Liu et al. | Alendronate-modified polymeric micelles for the treatment of breast cancer bone metastasis | |
| RU2014123622A (ru) | Терапевтические и/или диагностические наноносители, нацеленные на матриксные металлопротеазы (ммп) | |
| US20240066144A1 (en) | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use | |
| SZYMAŃSKI et al. | Nanotechnology in pharmaceutical and biomedical applications: Dendrimers | |
| JP2012518012A5 (OSRAM) | ||
| JP2016094425A5 (OSRAM) | ||
| Hegde et al. | An update on design and pharmacology of dendritic poly (l-lysine) | |
| Sun et al. | Substance P mediated DGLs complexing with DACHPt for targeting therapy of glioma | |
| WO2015183876A1 (en) | Bimodal fluorophore-labeled liposomes and associated methods and systems |